The Health Resources and Services Administration has approved eight manufacturer rebate plans under a new 340B pilot program set to launch Jan. 1. The initiative will replace upfront drug discounts ...

Discount drug program requires drug companies to sell deeply discounted drugs to hospitals that serve high numbers of ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

A program that started in the early nineties meant to help low-income patients, is at the forefront. But some worry that ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning whether those savings are being used ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

Most government support programs provide benefits directly to people, whether it is SNAP (Supplemental Nutritional Assistance Program), TANF (Temporary Assistance for Needy Families), or housing ...

Kansas’ Jerry Moran is part of a bipartisan group of U.S. senators working to reduce large hospital networks’ fraud and abuse ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.